Cancer Drug Developer Verastem Publishes Paper on Study of Merlin Loss

Scientists Publish Paper Declaring Merlin Deficiency as Predictor of Cancer Drugs’ Efficacy

Source: www.mesothelioma.com Via newsmixx: home News